Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.
February 26, 2013
FDA last week approved a first-of-its-kind late-stage breast cancer treatment that delivers a potent chemotherapy drug directly to cancer cells, leaving healthy cells relatively intact.
More than 1.5 million U.S. residents were diagnosed with invasive cancers in 2009—and a new CDC report indicates that new cases were most common in the Northeast.
Print All Daily Briefing Article from
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.